Navigation Links
Limited Value Found for First-Generation Heart Pumps
Date:11/25/2008

But newer models are much more effective, expert says

TUESDAY, Nov. 25 (HealthDay News) -- The first generation of ventricular assist devices (VADs) -- tiny pumps implanted in people with failing hearts -- are costly but provide limited benefits, a study finds.

However, the finding should not affect current medical practice, because the devices it describes are already being replaced by second- and third-generation VADS that are far superior, one expert said.

The study, published in the Journal of the American Medical Association, used data on almost 3,000 people who had VADs installed in a Medicare program between 2000 and 2006. Half the VADs were implanted as a primary treatment for heart failure, which is a progressive decline in the heart's ability to pump blood. The other half of the devices were implanted after a bypass surgery.

Fifty-five percent of those in the primary treatment group were discharged alive from the hospital, with 42 percent of dying over the following year, the researchers found. In the post-surgery group, a third were discharged alive from the hospital, and one quarter were alive a year later.

The total cost for patients in the primary treatment group was nearly $200,000 per person, the team estimated. The price tag was about $100,000 for those in the post-bypass group.

Given the cost and the uncertainty as to outcomes, "we need better data so we can have predictive tools in terms of understanding which patients will be successful and those who are extremely unlikely to live long with a VAD," said study lead author Dr. Adrian F. Hernandez, assistant professor of medicine at the Duke Cardiovascular Research Institute in Durham, N.C.

That data will come from a registry that is being kept of all the people who receive VADs, Hernandez said. Meanwhile, he said, "we certainly need more clinical studies to find out what is the right window for offering a patient a VAD."

The registry that now is being maintained will provide the needed information, said Dr. John V. Conte, director of the heart transplant and cardiovascular circulatory support program at Johns Hopkins University, but the findings of the new study can safely be disregarded, anyway, he said.

"The pump looked at in this study are not the pumps that primarily are used today," Conte said. "No second-generation pumps had yet been approved" at the time the study was conducted, he noted.

"This is a well-intentioned study, but in no way, shape or form should anyone make any conclusions based on this study," Conte contended.

First-generation VADs relied on a system of valves, subject to wear and tear, to control blood flow, he explained. "By 2003, we were starting to look at second-generation pumps that are smaller and more reliable. The ones available during this time period we know were not designed for long-term, many-year use," he said.

One second-generation VAD, which uses a rotating impeller to move blood, is now in general use, with more awaiting approval, Conte said. Third-generation pumps, which use electromagnetic impellers, have also made their appearance.

The latter "have no moving parts that can wear out," he said. "The second-generation pumps have bearings that can wear out."

And so a study of the first VADs to be implanted "is like talking about how the Model T works in today's environment," Conte said.

The study did make one valid point, he said. It found that results were best in hospitals that implanted many VADs and poorest in facilities implanting only one or two a year.

"Those people who do a large or moderate volume of procedures probably do a better job at it," Conte said. "We found a similar result in a study of heart transplants."

Information on the true value of VADs will start to emerge from the national registry, Conte said. "The patients we want to follow are those getting second- and third-generation pumps," he said. "Those are the ones we really need data on."

More information

There's more on these devices at the American Heart Association.



SOURCES: Adrian F. Hernandez, M.D., assistant professor of medicine, Duke Cardiovascular Research Institute, Durham, N.C.; John V. Conte, M.D., director, heart transplant and cardiovascular circulator support program, Johns Hopkins University, Baltimore; Nov. 26, 2008, Journal of the American Medical Association


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. GERD Not Limited to Grownups
2. Severe heart attack damage limited by hydrogen sulfide
3. New AHRQ Tools Help Pharmacies Better Serve Patients With Limited Health Literacy
4. Enstar Group Limited Announces Acquisition
5. Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia
6. Home-Based Senior Care Program Has Limited Benefits
7. Full-Service Community Hospitals Blast Misleading Letter to Candidates From Limited-Service Hospitals
8. Testosterone supplementation for older men appears to have limited benefit
9. Maintenance Software Company Bucks Trend, Offers Unlimited No-Charge Product Tech Support
10. Bobbi Brown Cosmetics Creates Limited-Edition Red Lip Palette in Partnership With The Heart Truths 2008 Red Dress Collection
11. Bobbi Brown Cosmetics Creates Limited-Edition Lip Palette in Partnership with The Heart Truths Red Dress Collection 2008 Fashion Show
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Limited Value Found for First-Generation Heart Pumps
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: